NCT00028821: 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors |
|
|
| Completed | 1 | 60 | US | 2-methoxyestradiol, 2-ME, 2-Methoxy Estradiol, 2ME2, Panzem, pharmacological study, pharmacological studies, laboratory biomarker analysis | National Cancer Institute (NCI) | Refractory Multiple Myeloma, Stage III Multiple Myeloma, Unspecified Adult Solid Tumor, Protocol Specific | 04/06 | | | |
NCT00030095: 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors |
|
|
| Completed | 1 | | US | 2-methoxyestradiol | National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | | | | |
